id	submitter_id	entity_type	entity_id	category	classification	created_datetime	status	notes
1883187b-941e-40e5-9d40-475ea44a4561	\N	masked_somatic_mutation	da05b2c6-1c92-42a8-b591-57f713a511f8	General	Notification	2022-02-28T13:29:52.086709-06:00	Approved	Variants from SomaticSniper are not included.
2e6c026b-e763-44f1-9af3-e6546af64844	\N	annotated_somatic_mutation	ccf74f7b-fad2-4e69-b9d4-9f72d639e329	General	Notification	2022-02-28T00:22:54.901420-06:00	Approved	Real somatic mutations were mistakenly labeled as LOH (Loss of Heterozygosity) in certain SomaticSniper VCF files.
59298880-bddb-4e84-9195-5d2d2d3d6818	\N	simple_somatic_mutation	a3f35c6f-3218-4a98-a738-da680364798b	General	Notification	2022-02-28T00:22:53.789702-06:00	Approved	Real somatic mutations were mistakenly labeled as LOH (Loss of Heterozygosity) in certain SomaticSniper VCF files.
97095c7b-8045-5715-9e63-3c43b44438b5	28435	case	5119aceb-ad95-4904-b6c0-a0a4b42c17d0	Neoadjuvant therapy	Notification	2015-07-01T00:00:00	Approved	During enrollment, the TSS discovered the patient had temozolomide chemotherapy prior to the TCGA cancer procurement.